Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 302

1.

Aetna's Compassionate Care Program: Sustained Value for Our Members with Advanced Illness.

Baquet-Simpson A, Spettell CM, Freeman AN, Bates AM, Paz HL, Mirsky R, Knecht DB, Brennan TA.

J Palliat Med. 2019 Nov;22(11):1324-1330. doi: 10.1089/jpm.2018.0359. Epub 2019 Jun 10.

PMID:
31180268
2.

Serum vitamin C levels modulate the lifespan and endoplasmic reticulum stress response pathways in mice synthesizing a nonfunctional mutant WRN protein.

Aumailley L, Dubois MJ, Brennan TA, Garand C, Paquet ER, Pignolo RJ, Marette A, Lebel M.

FASEB J. 2018 Jul;32(7):3623-3640. doi: 10.1096/fj.201701176R. Epub 2018 Feb 8.

3.

Increased Use of Adrenaline in the Management of Childhood Anaphylaxis Over the Last Decade.

Rueter K, Ta B, Bear N, Lucas M, Borland ML, Prescott SL.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1545-1552. doi: 10.1016/j.jaip.2017.11.038. Epub 2018 Jan 17.

PMID:
29342449
4.

Automatable algorithms to identify nonmedical opioid use using electronic data: a systematic review.

Canan C, Polinski JM, Alexander GC, Kowal MK, Brennan TA, Shrank WH.

J Am Med Inform Assoc. 2017 Nov 1;24(6):1204-1210. doi: 10.1093/jamia/ocx066. Review.

PMID:
29016967
5.

Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP).

Lindborg CM, Brennan TA, Wang H, Kaplan FS, Pignolo RJ.

Bone. 2018 Apr;109:153-157. doi: 10.1016/j.bone.2017.09.016. Epub 2017 Sep 28.

PMID:
28963080
6.

Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP).

Brennan TA, Lindborg CM, Bergbauer CR, Wang H, Kaplan FS, Pignolo RJ.

Bone. 2018 Apr;109:259-266. doi: 10.1016/j.bone.2017.08.023. Epub 2017 Aug 26.

PMID:
28851540
7.

Home infusion: Safe, clinically effective, patient preferred, and cost saving.

Polinski JM, Kowal MK, Gagnon M, Brennan TA, Shrank WH.

Healthc (Amst). 2017 Mar;5(1-2):68-80. doi: 10.1016/j.hjdsi.2016.04.004. Epub 2016 Apr 29. Review.

PMID:
28668202
8.

Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge.

Najafzadeh M, Schnipper JL, Shrank WH, Kymes S, Brennan TA, Choudhry NK.

Am J Manag Care. 2016 Oct;22(10):654-661.

9.

Predicting 1-Year Statin Adherence Among Prevalent Users: A Retrospective Cohort Study.

Krumme AA, Franklin JM, Isaman DL, Matlin OS, Tong AY, Spettell CM, Brennan TA, Shrank WH, Choudhry NK.

J Manag Care Spec Pharm. 2017 Apr;23(4):494-502. doi: 10.18553/jmcp.2017.23.4.494.

10.

Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial.

Choudhry NK, Krumme AA, Ercole PM, Girdish C, Tong AY, Khan NF, Brennan TA, Matlin OS, Shrank WH, Franklin JM.

JAMA Intern Med. 2017 May 1;177(5):624-631. doi: 10.1001/jamainternmed.2016.9627.

11.

Impact of CVS Pharmacy's Discontinuance of Tobacco Sales on Cigarette Purchasing (2012-2014).

Polinski JM, Howell B, Gagnon MA, Kymes SM, Brennan TA, Shrank WH.

Am J Public Health. 2017 Apr;107(4):556-562. doi: 10.2105/AJPH.2016.303612. Epub 2017 Feb 16.

12.

Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data.

Krumme AA, Sanfélix-Gimeno G, Franklin JM, Isaman DL, Mahesri M, Matlin OS, Shrank WH, Brennan TA, Brill G, Choudhry NK.

BMJ Open. 2016 Nov 9;6(11):e011015. doi: 10.1136/bmjopen-2015-011015.

13.

Physician training programs significantly improve diagnosis in cases coded as anaphylaxis over time: A major factor compounding time-trend data?

Rueter K, Ta B, Bear N, Lucas M, Prescott S.

J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):858-860. doi: 10.1016/j.jaip.2016.10.017. Epub 2016 Dec 20. No abstract available.

PMID:
28011240
14.

Longitudinal Patterns of Spending Enhance the Ability to Predict Costly Patients: A Novel Approach to Identify Patients for Cost Containment.

Lauffenburger JC, Franklin JM, Krumme AA, Shrank WH, Brennan TA, Matlin OS, Spettell CM, Brill G, Choudhry NK.

Med Care. 2017 Jan;55(1):64-73.

PMID:
27635600
15.

An Insurer's Care Transition Program Emphasizes Medication Reconciliation, Reduces Readmissions And Costs.

Polinski JM, Moore JM, Kyrychenko P, Gagnon M, Matlin OS, Fredell JW, Brennan TA, Shrank WH.

Health Aff (Millwood). 2016 Jul 1;35(7):1222-9. doi: 10.1377/hlthaff.2015.0648.

PMID:
27385237
16.

Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women.

Bateman BT, Franklin JM, Bykov K, Avorn J, Shrank WH, Brennan TA, Landon JE, Rathmell JP, Huybrechts KF, Fischer MA, Choudhry NK.

Am J Obstet Gynecol. 2016 Sep;215(3):353.e1-353.e18. doi: 10.1016/j.ajog.2016.03.016. Epub 2016 Mar 17.

17.

Finding Common Ground: Professionalism and Acthar Prescribing Practices.

Liss D, Brennan TA, Manaker S.

Chest. 2016 Mar;149(3):611-2. doi: 10.1016/j.chest.2015.12.020. Epub 2016 Jan 14. No abstract available.

PMID:
26836915
18.

Aging alters bone-fat reciprocity by shifting in vivo mesenchymal precursor cell fate towards an adipogenic lineage.

Singh L, Brennan TA, Russell E, Kim JH, Chen Q, Brad Johnson F, Pignolo RJ.

Bone. 2016 Apr;85:29-36. doi: 10.1016/j.bone.2016.01.014. Epub 2016 Jan 19.

19.

The adherence impact of a program offering specialty pharmacy services to patients using retail pharmacies.

Moore JM, Matlin OS, Lotvin AM, Brennan TA, Falkenrath R, Kymes S, Singh SC, Kyrychenko P, Shrank WH.

J Am Pharm Assoc (2003). 2016 Jan;56(1):47-53. doi: 10.1016/j.japh.2015.11.003.

PMID:
26802920
20.

Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.

Shirneshan E, Kyrychenko P, Matlin OS, Avila JP, Brennan TA, Shrank WH.

J Clin Pharm Ther. 2016 Feb;41(1):64-9. doi: 10.1111/jcpt.12349. Epub 2016 Jan 18.

PMID:
26778812
21.

Community pharmacy automatic refill program improves adherence to maintenance therapy and reduces wasted medication.

Matlin OS, Kymes SM, Averbukh A, Choudhry NK, Brennan TA, Bunton A, Ducharme TA, Simmons PD, Shrank WH.

Am J Manag Care. 2015 Nov;21(11):785-91.

22.

Predicting adherence trajectory using initial patterns of medication filling.

Franklin JM, Krumme AA, Shrank WH, Matlin OS, Brennan TA, Choudhry NK.

Am J Manag Care. 2015 Sep 1;21(9):e537-44.

23.

Comparative effectiveness of generic versus brand-name antiepileptic medications.

Gagne JJ, Kesselheim AS, Choudhry NK, Polinski JM, Hutchins D, Matlin OS, Brennan TA, Avorn J, Shrank WH.

Epilepsy Behav. 2015 Nov;52(Pt A):14-8. doi: 10.1016/j.yebeh.2015.08.014. Epub 2015 Sep 19.

PMID:
26386779
24.

Association Between Narrow Pharmacy Networks and Medication Adherence.

Polinski JM, Matlin OS, Sullivan C, Gagnon M, Brennan TA, Shrank WH.

JAMA Intern Med. 2015 Nov;175(11):1850-3. doi: 10.1001/jamainternmed.2015.4582. No abstract available.

PMID:
26348504
25.

Patients' Satisfaction with and Preference for Telehealth Visits.

Polinski JM, Barker T, Gagliano N, Sussman A, Brennan TA, Shrank WH.

J Gen Intern Med. 2016 Mar;31(3):269-75. doi: 10.1007/s11606-015-3489-x. Epub 2015 Aug 13.

26.

New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines.

Shrank WH, Barlow JF, Brennan TA.

JAMA. 2015 Oct 13;314(14):1443-4. doi: 10.1001/jama.2015.10017. No abstract available.

PMID:
26258765
27.

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.

Plimack ER, Dunbrack RL, Brennan TA, Andrake MD, Zhou Y, Serebriiskii IG, Slifker M, Alpaugh K, Dulaimi E, Palma N, Hoffman-Censits J, Bilusic M, Wong YN, Kutikov A, Viterbo R, Greenberg RE, Chen DY, Lallas CD, Trabulsi EJ, Yelensky R, McConkey DJ, Miller VA, Golemis EA, Ross EA.

Eur Urol. 2015 Dec;68(6):959-67. doi: 10.1016/j.eururo.2015.07.009. Epub 2015 Aug 1.

28.

Patient Use of Email, Facebook, and Physician Websites to Communicate with Physicians: A National Online Survey of Retail Pharmacy Users.

Lee JL, Choudhry NK, Wu AW, Matlin OS, Brennan TA, Shrank WH.

J Gen Intern Med. 2016 Jan;31(1):45-51. doi: 10.1007/s11606-015-3374-7.

29.

Rationale and design of the Randomized Evaluation to Measure Improvements in Non-adherence from Low-Cost Devices (REMIND) trial.

Choudhry NK, Krumme AA, Ercole PM, Girdish C, Isaman DL, Matlin OS, Brennan TA, Shrank WH, Franklin JM.

Contemp Clin Trials. 2015 Jul;43:53-9. doi: 10.1016/j.cct.2015.05.006. Epub 2015 May 12.

PMID:
25979316
30.

Randomized trial of four financial-incentive programs for smoking cessation.

Halpern SD, French B, Small DS, Saulsgiver K, Harhay MO, Audrain-McGovern J, Loewenstein G, Brennan TA, Asch DA, Volpp KG.

N Engl J Med. 2015 May 28;372(22):2108-17. doi: 10.1056/NEJMoa1414293. Epub 2015 May 13.

31.

Association between trajectories of statin adherence and subsequent cardiovascular events.

Franklin JM, Krumme AA, Tong AY, Shrank WH, Matlin OS, Brennan TA, Choudhry NK.

Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1105-13. doi: 10.1002/pds.3787. Epub 2015 Apr 22.

PMID:
25903307
32.

Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques.

Franklin JM, Shrank WH, Lii J, Krumme AK, Matlin OS, Brennan TA, Choudhry NK.

Health Serv Res. 2016 Feb;51(1):220-39. doi: 10.1111/1475-6773.12310. Epub 2015 Apr 16.

33.

Biosimilar competition in the United States: statutory incentives, payers, and pharmacy benefit managers.

Falit BP, Singh SC, Brennan TA.

Health Aff (Millwood). 2015 Feb;34(2):294-301. doi: 10.1377/hlthaff.2014.0482.

PMID:
25646110
34.

Prescription drug insurance coverage and patient health outcomes: a systematic review.

Kesselheim AS, Huybrechts KF, Choudhry NK, Fulchino LA, Isaman DL, Kowal MK, Brennan TA.

Am J Public Health. 2015 Feb;105(2):e17-30. doi: 10.2105/AJPH.2014.302240. Review.

35.

Costs of new treatments for hepatitis C infection--reply.

Brennan TA, Shrank WH.

JAMA. 2014 Nov 26;312(20):2168-9. doi: 10.1001/jama.2014.14352. No abstract available.

PMID:
25423230
36.

Quality of care at retail clinics for 3 common conditions.

Shrank WH, Krumme AA, Tong AY, Spettell CM, Matlin OS, Sussman A, Brennan TA, Choudhry NK.

Am J Manag Care. 2014 Oct;20(10):794-801.

37.

Cigarette purchases at pharmacies by patients at high risk of smoking-related illness.

Krumme AA, Choudhry NK, Shrank WH, Brennan TA, Matlin OS, Brill G, Gagne JJ.

JAMA Intern Med. 2014 Dec;174(12):2031-2. doi: 10.1001/jamainternmed.2014.5307. No abstract available.

PMID:
25329817
38.

Specialty medications: traditional and novel tools can address rising spending on these costly drugs.

Lotvin AM, Shrank WH, Singh SC, Falit BP, Brennan TA.

Health Aff (Millwood). 2014 Oct;33(10):1736-44. doi: 10.1377/hlthaff.2014.0511.

PMID:
25288417
39.

Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.

Gagne JJ, Choudhry NK, Kesselheim AS, Polinski JM, Hutchins D, Matlin OS, Brennan TA, Avorn J, Shrank WH.

Ann Intern Med. 2014 Sep 16;161(6):400-7. doi: 10.7326/M13-2942.

PMID:
25222387
40.

The special case of gene therapy pricing.

Brennan TA, Wilson JM.

Nat Biotechnol. 2014 Sep;32(9):874-6. doi: 10.1038/nbt.3003.

PMID:
25203033
41.

Ending the sale of cigarettes at US pharmacies--reply.

Brennan TA, Schroeder S.

JAMA. 2014 Aug 6;312(5):560. doi: 10.1001/jama.2014.7572. No abstract available.

PMID:
25096706
42.

Did HEDIS get it right? Evaluating the quality of a quality measure: adherence to β-blockers and cardiovascular outcomes after myocardial infarction.

Sanfélix-Gimeno G, Franklin JM, Shrank WH, Carlo M, Tong AY, Reisman L, Matlin OS, Brennan TA, Choudhry NK.

Med Care. 2014 Jul;52(7):669-76. doi: 10.1097/MLR.0000000000000148.

PMID:
24926716
43.

Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications.

Desai NR, Krumme AA, Schneeweiss S, Shrank WH, Brill G, Pezalla EJ, Spettell CM, Brennan TA, Matlin OS, Avorn J, Choudhry NK.

Am J Med. 2014 Nov;127(11):1075-82.e1. doi: 10.1016/j.amjmed.2014.05.013. Epub 2014 May 21.

PMID:
24859719
44.

Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.

Franklin JM, Choudhry NK, Uscher-Pines L, Brill G, Matlin OS, Fischer MA, Schneeweiss S, Avorn J, Brennan TA, Shrank WH.

Am J Public Health. 2014 Jun;104(6):1052-8. doi: 10.2105/AJPH.2013.301762. Epub 2014 Apr 17.

45.

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.

Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR.

J Clin Oncol. 2014 Jun 20;32(18):1895-901. doi: 10.1200/JCO.2013.53.2465. Epub 2014 May 12.

46.

Eliminating medication copayments reduces disparities in cardiovascular care.

Choudhry NK, Bykov K, Shrank WH, Toscano M, Rawlins WS, Reisman L, Brennan TA, Franklin JM.

Health Aff (Millwood). 2014 May;33(5):863-70. doi: 10.1377/hlthaff.2013.0654.

PMID:
24799585
47.

Mouse models of telomere dysfunction phenocopy skeletal changes found in human age-related osteoporosis.

Brennan TA, Egan KP, Lindborg CM, Chen Q, Sweetwyne MT, Hankenson KD, Xie SX, Johnson FB, Pignolo RJ.

Dis Model Mech. 2014 May;7(5):583-92. doi: 10.1242/dmm.014928. Epub 2014 Mar 13.

48.

Five features of value-based insurance design plans were associated with higher rates of medication adherence.

Choudhry NK, Fischer MA, Smith BF, Brill G, Girdish C, Matlin OS, Brennan TA, Avorn J, Shrank WH.

Health Aff (Millwood). 2014 Mar;33(3):493-501. doi: 10.1377/hlthaff.2013.0060. Epub 2014 Feb 12.

PMID:
24522551
49.

Ending sales of tobacco products in pharmacies.

Brennan TA, Schroeder SA.

JAMA. 2014 Mar 19;311(11):1105-6. doi: 10.1001/jama.2014.686. No abstract available.

PMID:
24500655
50.

Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification.

Culbert AL, Chakkalakal SA, Theosmy EG, Brennan TA, Kaplan FS, Shore EM.

Stem Cells. 2014 May;32(5):1289-300. doi: 10.1002/stem.1633.

Supplemental Content

Loading ...
Support Center